Literature DB >> 8112378

Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

R Nau1, G Zysk, A Thiel, H W Prange.   

Abstract

Various parameters which may be useful in quantification of drug transit from blood into CSF and vice versa after a short duration infusion are compared here by recalculating previously published data from our group. Due to the slower entry into and elimination from the CSF compartment as compared to the central compartment, the ratio of drug concentrations in CSF and serum sampled at the same time increase with time after an infusion. Therefore, concentration quotients of simultaneously drawn blood and CSF are inadequate to characterise CSF penetration. The ratio of the areas under the concentration-time curves in a body fluid and serum (AUCbody fluid/AUCs) is an established measure to quantify overall penetration from the central into a peripheral compartment. AUCCSF/AUCs is closely correlated with the quotient of the maximum CSF and serum concentrations (CmaxCSF/CmaxS) (rs = 0.87, n = 42, P < 0.001) and with the rate constant of distribution in CSF (CLin/VCSF) (rs = 0.80, n = 42, P < 0.001). Since CmaxCSF/CmaxS depends on the mode of drug administration, it is suggested that AUCCSF/AUCs be used to quantify overall drug transit into CSF. CLin/VCSF is of use when CSF can only be sampled once, or when the velocity of the transit of a drug into CSF is to be described. The CSF exit rate constant (CLout/VCSF) characterises elimination from CSF independent of the elimination from serum and may be applied to estimate the formation rate of CSF; in the present study it averaged 20 ml/h.

Entities:  

Mesh:

Year:  1993        PMID: 8112378     DOI: 10.1007/bf00315520

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  46 in total

1.  Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis.

Authors:  M Wolff; P Chavanet; A Kazmierczak; A Pechinot; C Dematons; H Portier; B Lenfant
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

Review 2.  Structural aspects of brain barriers, with special reference to the permeability of the cerebral endothelium and choroidal epithelium.

Authors:  B van Deurs
Journal:  Int Rev Cytol       Date:  1980

3.  Ceftriaxone pharmacokinetics in the central nervous system.

Authors:  R Spector
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

4.  The effect of dexamethasone on the rate of formation of cerebrospinal fluid in the monkey.

Authors:  A N Martins; A Ramirez; L S Solomon; G M Wiese
Journal:  J Neurosurg       Date:  1974-11       Impact factor: 5.115

5.  Mechanism for intracranial hypertension during experimental subarachnoid hemorrhage: acute malfunction of arachnoid villi by components of plasma.

Authors:  R N Johnson; C J Maffeo; R G Dacey; A B Butler; N H Bass
Journal:  Trans Am Neurol Assoc       Date:  1978

6.  Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone.

Authors:  W M Scheld; R G Dacey; H R Winn; J E Welsh; J A Jane; M A Sande
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

7.  Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol.

Authors:  R Nau; F J Prins; H Kolenda; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.

Authors:  H Lode; G Höffken; P Olschewski; B Sievers; A Kirch; K Borner; P Koeppe
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

9.  Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.

Authors:  J C Pioget; M Wolff; E Singlas; M J Laisne; B Clair; B Regnier; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

10.  Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; J Martell; S Sharifi; H Kolenda; J Bircher
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

View more
  19 in total

1.  Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges.

Authors:  M V Moretti; S Pauluzzi; M Cesana
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.

Authors:  L F López-Cortés; R Ruiz-Valderas; M J Lucero-Muñoz; E Cordero; M T Pastor-Ramos; J Marquez
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 3.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

Review 4.  Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.

Authors:  R Nau; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

5.  Understanding central nervous system efficacy of antimicrobials.

Authors:  Pierre Tattevin; Tom Solomon; Matthijs C Brouwer
Journal:  Intensive Care Med       Date:  2018-06-23       Impact factor: 17.440

6.  Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children.

Authors:  Anne Mannila; Hannu Kokki; Marja Heikkinen; Merja Laisalmi; Marko Lehtonen; Hanna L Louhisto; Tomi Järvinen; Jouko Savolainen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.

Authors:  Nithya Srinivas; Kaitlyn Maffuid; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

8.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

9.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Authors:  R Nau; H W Prange; M Kinzig; A Frank; A Dressel; P Scholz; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.

Authors:  B Bannwarth; F Lapicque; F Pehourcq; P Gillet; T Schaeverbeke; C Laborde; J Dehais; A Gaucher; P Netter
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.